Longeveron Inc. financial data

Symbol
LGVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1951 Nw 7 Th Avenue, Suite 520, Miami, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
LONGEVERON LLC (to 2/10/2021)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 302 % -4.67%
Debt-to-equity 41.3 % -2.8%
Return On Equity -142 % +1.81%
Return On Assets -101 % +0.98%
Operating Margin -2.09K % -21.8%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 19M USD +5.64%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.51M shares +208%
Weighted Average Number of Shares Outstanding, Diluted 6.51M shares +208%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 978K USD -13.5%
Revenue from Contract with Customer, Excluding Assessed Tax 773K USD +415%
Cost of Revenue 499K USD +7.54%
Research and Development Expense 8.3M USD -19.5%
Selling and Marketing Expense 783K USD -25.5%
General and Administrative Expense 9.95M USD -5.64%
Costs and Expenses 200K USD -66.7%
Operating Income (Loss) -17.7M USD +15.1%
Nonoperating Income (Expense) -239K USD +318%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -17.9M USD +9.7%
Earnings Per Share, Basic 2.87 USD/shares +87.8%
Earnings Per Share, Diluted 2.87 USD/shares +87.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.8M USD +1058%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 380K USD +296%
Assets, Current 23.8M USD +371%
Property, Plant and Equipment, Net 2.62M USD +3.07%
Operating Lease, Right-of-Use Asset 970K USD -25.4%
Intangible Assets, Net (Excluding Goodwill) 2.35M USD -7.56%
Other Assets, Noncurrent 203K USD
Assets 29.9M USD +157%
Accounts Payable, Current 887K USD +7%
Accrued Liabilities, Current 1.48M USD +0.41%
Contract with Customer, Liability, Current 118K USD
Liabilities, Current 3.1M USD -8.66%
Operating Lease, Liability, Noncurrent 983K USD -38.5%
Other Liabilities, Noncurrent 199K USD
Liabilities 4.28M USD -14.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD +99.7%
Retained Earnings (Accumulated Deficit) -106M USD -33.7%
Stockholders' Equity Attributable to Parent 25.6M USD +286%
Liabilities and Equity 29.9M USD +157%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.09M USD +47.2%
Net Cash Provided by (Used in) Financing Activities 63K USD
Net Cash Provided by (Used in) Investing Activities 14K USD -96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22.8M USD +1058%
Deferred Tax Assets, Valuation Allowance 13.8M USD +19.5%
Deferred Tax Assets, Gross 14.2M USD +18.8%
Operating Lease, Liability 1.6M USD
Depreciation 200K USD 0%
Payments to Acquire Property, Plant, and Equipment 16K USD -61.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18M USD +10.8%
Lessee, Operating Lease, Liability, to be Paid 1.7M USD
Property, Plant and Equipment, Gross 7.61M USD +11.7%
Operating Lease, Liability, Current 616K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 682K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 682K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 105K USD -47.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 170K USD
Deferred Tax Assets, Operating Loss Carryforwards 7.79M USD +27.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 169K USD -24.6%
Additional Paid in Capital 131M USD +52.5%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 682K USD
Amortization of Intangible Assets 200K USD 0%
Depreciation, Depletion and Amortization 700K USD -12.5%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 171K USD
Deferred Tax Assets, Net of Valuation Allowance 391K USD -3.7%
Share-based Payment Arrangement, Expense 500K USD 0%
Operating Leases, Future Minimum Payments, Due in Three Years 682K USD
Operating Leases, Future Minimum Payments Due 2.39M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%